Humasis Co. Ltd.
KOE: 205470.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Sung-gon Kim
- Employees
- 71
- Headquarters
- Anyang, South Korea
- IPO year
- 2017
- Market cap
- ₩90.7B
- Website
- http://www.humasis.com
Loading 205470…
Loading profile data…Frequently asked questions about 205470
What does Humasis Co. Ltd. (205470.KQ) do?
Humasis Co. Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. It offers pregnancy and ovulation self-test products; Hubi-Quan Pro, a self-contained and cartridge reader...
Where does 205470.KQ trade?
Humasis Co. Ltd. (205470.KQ) trades on the KOSDAQ.
What sector is 205470.KQ in?
Humasis Co. Ltd. (205470.KQ) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Humasis Co. Ltd.?
Sung-gon Kim is the chief executive officer of Humasis Co. Ltd. (205470.KQ).
Where is Humasis Co. Ltd. headquartered?
Humasis Co. Ltd. is headquartered in South Korea.
Does 205470.KQ pay a dividend?
Humasis Co. Ltd. (205470.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 205470.KQ go public?
Humasis Co. Ltd. (205470.KQ) completed its initial public offering in 2017.